Merck & Co. — how they publish

10 posts · curated by ViralLoop

19 posts from @Merck, Apr 2024 to Oct 2025: a typical post earns 13 likes and 2 replies. That is more than 68% of the 275 other S&P 500 companies we hold content for. About 1 in 2 of their posts announces something.

Merck@Merck

Today, we officially break ground on our new biologics commercialization and launch facility in Wilmington, Delaware. This $1 billion, 470,000 square-foot facility will feature advanced laboratory, manufacturing and warehouse capabilities. Learn more: t.co

Opens with an announcement

Merck@Merck

Today, we announced positive topline results from our late-stage clinical study in respiratory syncytial virus (#RSV) disease. Learn more: t.co

Opens with an announcement

Merck@Merck

Today we broke ground on a $3B, 400,000-sq. foot pharmaceutical manufacturing facility at our Elkton, Virginia site. Real projects. Not just promises. t.co

Opens with an announcement

Merck@Merck

Our Q1 2025 #earnings results are live. Check out our full $MRK financial summary and key highlights: t.co

Opens with a number

Merck@Merck

Today, we announced that we’ve expanded our global development and commercialization agreement with @DaiichiSankyoUS. Read more here: t.co

Opens with an announcement

Merck@Merck

We're pleased to announce the #FDA approval of an option to help protect against invasive #pneumococcal disease and pneumococcal #pneumonia. Learn more: t.co

Opens with an announcement

Merck@Merck

Today we announced that we’ve exercised our option to convert our ongoing co-development and co-commercialization agreement with Orion Corporation into an exclusive global license. Learn more: t.co

Opens with an announcement

Merck@Merck

Today, we announced the completion of our acquisition of EyeBio, further diversifying our late-stage pipeline and accelerating our research presence in #ophthalmology. Read more: t.co

Opens with an announcement

Merck@Merck

Learn more about our latest update in triple-negative #breastcancer: t.co

Opens with an observation

Merck@Merck

We’re excited to share our latest #HIV updates, which will be presented at IAS 2025. Learn more: t.co

Opens with an observation